Agios Pharmaceuticals
AGIO
#5153
Rank
$1.71 B
Marketcap
$28.83
Share price
1.76%
Change (1 day)
-4.54%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2026 (TTM): -$0.48 Billion USD

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are $66.04 Million USD. In 2025 the company made an earning of -$0.48 Billion USD a decrease over its 2024 earnings that were of -$0.43 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$0.48 Billion0.72%
2025 -$0.48 Billion10.9%
2024 -$0.43 Billion8.75%
2023 -$0.4 Billion0.63%
2022 -$0.39 Billion2.81%
2021 -$0.38 Billion10.58%
2020 -$0.35 Billion-18.41%
2019 -$0.42 Billion15.72%
2018 -$0.37 Billion12.99%
2017 -$0.33 Billion59.61%
2016 -$0.21 Billion69.32%
2015 -$0.12 Billion119.28%
2014 -$54.14 Million39.22%
2013 -$38.89 Million69.1%
2012 -$23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
$10.59 B-2,327.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$31.12 B-6,645.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$10.01 B-2,205.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-$0.14 Billion-70.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
$1.00 B-310.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$0.38 B-181.09%๐Ÿ‡บ๐Ÿ‡ธ USA